Cargando…
Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review
Tianeptine is an antidepressant drug approved for the treatment of major depressive disorder in countries other than the US. It is classified as an atypical tricyclic antidepressant and has shown potential benefits in addressing anxiety and irritable bowel disease. However, it is important to note t...
Autores principales: | Edinoff, Amber N., Sall, Saveen, Beckman, Scott P., Koepnick, Andrew D., Gold, Logan C., Jackson, Eric D., Wenger, Danielle M., Cornett, Elyse M., Murnane, Kevin S., Kaye, Adam M., Kaye, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444703/ https://www.ncbi.nlm.nih.gov/pubmed/37453966 http://dx.doi.org/10.1007/s40122-023-00539-5 |
Ejemplares similares
-
Ketamine Evolving Clinical Roles and Potential Effects with Cognitive, Motor and Driving Ability
por: Edinoff, Amber N., et al.
Publicado: (2023) -
The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
por: Gassaway, M M, et al.
Publicado: (2014) -
Transcranial Stimulation for the Treatment of Stimulant Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2023) -
Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging
por: Murnane, Kevin S, et al.
Publicado: (2023) -
Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021)